{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:24:48Z","timestamp":1795015488917,"version":"4.10.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Fibrinolytic phenotypes have been implicated in postinjury pathophysiology and outcomes. While prehospital tranexamic acid (TXA) administration has demonstrated survival benefits, the interaction between TXA administration and distinct fibrinolytic profiles remains poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We analyzed data from a harmonized dataset combining 2 prospective trials evaluating prehospital TXA use in trauma (Prehospital Tranexamic Acid Use for Traumatic Brain Injury and the Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial). Patients were stratified by initial thromboelastographic (TEG) LY30 into fibrinolytic shutdown (&lt;0.9%), hyperfibrinolysis (&gt;3%), and physiological fibrinolysis (0.9\u20133%). The primary outcome was 30-day mortality. Secondary outcomes included 24-hour mortality and adverse events. Multivariable regression adjusted for TXA administration, fibrinolysis phenotypes, age, mechanism of injury, injury severity score, and shock index on presentation to the hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Among 1,249 patients, 30-day mortality was 14.5% in the fibrinolytic shutdown group, 6.7% in the hyperfibrinolysis group, and 6.5% in the physiological fibrinolysis group. After multivariable regression, hyperfibrinolysis was associated with increased risk of death (HR 2.87; 95% CI: 1.10\u20137.53;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      0.03). Patients with fibrinolytic shutdown who were randomized to TXA had decreased risk of death (HR 0.32; 95% CI: 0.11\u20130.91;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =0.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>This multitrial analysis revealed greater statistically significant differences between fibrinolytic phenotypes than analysis of each trial alone. Fibrinolytic phenotypes were independently associated with mortality. Fibrinolytic shutdown in patients randomized to receive TXA was associated with lower risk of death. These findings support the relevance of fibrinolysis profiling during early trauma care and underscore the need for larger studies to further elucidate the prognostic and therapeutic implications in trauma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LEVEL OF EVIDENCE:<\/jats:title>\n                    <jats:p>Prognostic and Epidemiological; Level III.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ta.0000000000005092","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:02:09Z","timestamp":1791558129000},"page":"999-1010","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Survival benefit of prehospital TXA in fibrinolytic shutdown: Insights from two prospective trauma trials"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1274-2138","authenticated-orcid":false,"given":"James E.","family":"Kenny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra MP","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Benchiba-Charron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Chrenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswadev","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Gruen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Medcalf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Rowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Sperry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"issue":"2","key":"R1-20261118","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/TA.0000000000004170","article-title":"Trauma-induced coagulopathy: what you need to know","volume":"96","author":"Buzzard","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"R2-20261118","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/TA.0000000000001718","article-title":"Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator","volume":"83","author":"Moore","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"R3-20261118","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jamcollsurg.2016.01.006","article-title":"Acute fibrinolysis shutdown after injury occurs frequently and increases mortality: a multicenter evaluation of 2,540 severely injured patients","volume":"222","author":"Moore","year":"2016","journal-title":"J Am Coll Surg"},{"issue":"3","key":"R5-20261118","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MBC.0000000000001008","article-title":"Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo","volume":"32","author":"Draxler","year":"2021","journal-title":"Blood Coagul Fibrinolysis Int J Haemost Thromb"},{"issue":"6 Suppl 1","key":"R6-20261118","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/TA.0000000000000634","article-title":"Postinjury fibrinolysis shutdown: rationale for selective tranexamic acid","volume":"78","author":"Moore","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"issue":"7","key":"R7-20261118","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.joms.2020.02.026","article-title":"Orthognathic surgery-induced fibrinolytic shutdown is amplified by tranexamic acid","volume":"78","author":"Sidelmann","year":"2020","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"R8-20261118","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jamcollsurg.2019.03.015","article-title":"Does tranexamic acid improve clot strength in severely injured patients who have elevated fibrin degradation products and low fibrinolytic activity, measured by thrombelastography?","volume":"229","author":"Moore","year":"2019","journal-title":"J Am Coll Surg"},{"issue":"10","key":"R9-20261118","first-page":"1","article-title":"The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients","volume":"17","author":"Roberts","year":"2013","journal-title":"Health Technol Assess Winch Engl"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"86","DOI":"10.12688\/wellcomeopenres.14700.2","article-title":"Tranexamic acid for significant traumatic brain injury (The CRASH-3 trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial","volume":"3","author":"Roberts","year":"2018","journal-title":"Wellcome Open Res"},{"issue":"5","key":"R11-20261118","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/TA.0000000000004315","article-title":"Prehospital tranexamic acid is associated with a survival benefit without an increase in complications: results of two harmonized randomized clinical trials","volume":"97","author":"Mazzei","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"R12-20261118","first-page":"11","article-title":"Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: a double-blind, placebo-controlled, randomized clinical trial","volume":"156","author":"Guyette","year":"2020","journal-title":"JAMA Surg"},{"issue":"4","key":"R13-20261118","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/TA.0000000000004354","article-title":"The effects of prehospital TXA on mortality and neurologic outcomes in patients with traumatic intracranial hemorrhage: A subgroup analysis from the prehospital TXA for TBI trial","volume":"97","author":"Rowell","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"R14-20261118","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa2215457","article-title":"Prehospital tranexamic acid for severe trauma","volume":"389","author":"Gruen","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"R15-20261118","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TA.0000000000002932","article-title":"Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury","volume":"89","author":"Dixon","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"R16-20261118","doi-asserted-by":"crossref","first-page":"e001346","DOI":"10.1136\/tsaco-2023-001346","article-title":"Missingness matters: a secondary analysis of thromboelastography measurements from a recent prehospital randomized tranexamic acid clinical trial","volume":"9","author":"Donohue","year":"2024","journal-title":"Trauma Surg Acute Care Open"},{"issue":"4","key":"R17-20261118","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jamcollsurg.2016.12.018","article-title":"Persistent fibrinolysis shutdown is associated with increased mortality in severely injured trauma patients","volume":"224","author":"Meizoso","year":"2017","journal-title":"J Am Coll Surg"},{"issue":"10","key":"R18-20261118","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/bloodadvances.2019000092","article-title":"Tranexamic acid modulates the immune response and reduces postsurgical infection rates","volume":"3","author":"Draxler","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"R19-20261118","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13049-024-01236-8","article-title":"Trauma induced coagulopathy is limited to only one out of four shock induced endotheliopathy (SHINE) phenotypes among moderate-severely injured trauma patients: an exploratory analysis","volume":"32","author":"Johansson","year":"2024","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"2","key":"R20-20261118","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/TA.0000000000004177","article-title":"A comparative analysis of tranexamic acid dosing strategies in traumatic major hemorrhage","volume":"96","author":"Gunn","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"R21-20261118","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/jth.12078","article-title":"The incidence and magnitude of fibrinolytic activation in trauma patients","volume":"11","author":"Raza","year":"2013","journal-title":"J Thromb Haemost JTH"},{"issue":"3","key":"R22-20261118","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/TA.0000000000004669","article-title":"Association between coagulation biomarkers, intracranial hemorrhage types, and tranexamic acid treatments in early traumatic brain injury","volume":"99","author":"Minoza","year":"2025","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"R23-20261118","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/ALN.0000000000004268","article-title":"Coagulopathy underlying rotational thromboelastometry derangements in trauma patients: a prospective observational multicenter study","volume":"137","author":"Dujardin","year":"2022","journal-title":"Anesthesiology"},{"issue":"2","key":"R24-20261118","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1213\/ANE.0000000000002708","article-title":"The impact of prehospital tranexamic acid on blood coagulation in trauma patients","volume":"126","author":"Stein","year":"2018","journal-title":"Anesth Analg"},{"issue":"1","key":"R25-20261118","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/ALN.0000000000004036","article-title":"Temporal transitions in fibrinolysis after trauma: adverse outcome is principally related to late hypofibrinolysis","volume":"136","author":"Rossetto","year":"2022","journal-title":"Anesthesiology"},{"issue":"6","key":"R26-20261118","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/TA.0b013e3182aa9c9f","article-title":"Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy","volume":"75","author":"Chapman","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"R27-20261118","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/XCS.0000000000001027","article-title":"Differentiating pathologic from physiologic fibrinolysis: not as simple as conventional thrombelastography","volume":"239","author":"Moore","year":"2024","journal-title":"J Am Coll Surg"},{"key":"R28-20261118","first-page":"126","article-title":"Hyperfibrinolysis is associated with complement activation following trauma","volume":"126","author":"Barrett","year":"2025","journal-title":"Thromb Haemost"},{"key":"R29-20261118","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/XCS.0000000000001606","article-title":"Tranexamic acid and systemic complement activation in traumatic brain injury patients","volume":"241","author":"Maginot","year":"2025","journal-title":"J Am Coll Surg"},{"issue":"4","key":"R30-20261118","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/TA.0000000000004526","article-title":"The tissue-plasminogen activator-challenged thromboelastography provides a comprehensive assessment of fibrinolysis in the severely injured","volume":"98","author":"Maginot","year":"2025","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"R31-20261118","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/SLA.0000000000002733","article-title":"The S100A10 pathway mediates an occult hyperfibrinolytic subtype in trauma patients","volume":"269","author":"Gall","year":"2019","journal-title":"Ann Surg"},{"issue":"3","key":"R32-20261118","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/SHK.0000000000001160","article-title":"TEG lysis shutdown represents coagulopathy in bleeding trauma patients: analysis of the PROPPR cohort","volume":"51","author":"Cardenas","year":"2019","journal-title":"Shock Augusta Ga"},{"issue":"2","key":"R33-20261118","first-page":"113","article-title":"Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study","volume":"147","author":"Morrison","year":"2012","journal-title":"Arch Surg Chic Ill 1960"},{"issue":"3","key":"R34-20261118","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/SLA.0000000000002355","article-title":"Trending fibrinolytic dysregulation: fibrinolysis shutdown in the days after injury is associated with poor outcome in severely injured children","volume":"266","author":"Leeper","year":"2017","journal-title":"Ann Surg"},{"issue":"1","key":"R35-20261118","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12959-025-00723-x","article-title":"Coagulopathy as a predictor of the effectiveness of tranexamic acid in severe blunt trauma: a multicenter retrospective study","volume":"23","author":"Takahashi","year":"2025","journal-title":"Thromb J"},{"issue":"12","key":"R36-20261118","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1111\/jth.14603","article-title":"Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis","volume":"17","author":"Draxler","year":"2019","journal-title":"J Thromb Haemost JTH"},{"issue":"1","key":"R37-20261118","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/TA.0000000000002092","article-title":"Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner","volume":"86","author":"Barrett","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"R38-20261118","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/jth.14338","article-title":"Increased urokinase and consumption of \u03b12 -antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay","volume":"17","author":"Longstaff","year":"2019","journal-title":"J Thromb Haemost JTH"},{"issue":"10","key":"R39-20261118","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1111\/jth.15015","article-title":"Sex-dependent effects of tranexamic acid on blood-brain barrier permeability and the immune response following traumatic brain injury in mice","volume":"18","author":"Daglas","year":"2020","journal-title":"J Thromb Haemost JTH"},{"issue":"1","key":"R40-20261118","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00134-020-06266-1","article-title":"Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial","volume":"47","author":"Baksaas-Aasen","year":"2021","journal-title":"Intensive Care Med"},{"issue":"5","key":"R41-20261118","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/ALN.0000000000005183","article-title":"Correction of trauma-induced coagulopathy by goal-directed therapy: a secondary analysis of the ITACTIC trial","volume":"141","author":"Lindsay","year":"2024","journal-title":"Anesthesiology"},{"key":"R42-20261118","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fped.2018.00142","article-title":"The role of inflammation in venous thromboembolism","volume":"6","author":"Branchford","year":"2018","journal-title":"Front Pediatr"},{"issue":"1","key":"R43-20261118","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.24558","article-title":"Tranexamic acid-associated seizures: causes and treatment","volume":"79","author":"Lecker","year":"2016","journal-title":"Ann Neurol"},{"issue":"5","key":"R44-20261118","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/TA.0000000000004572","article-title":"Tranexamic acid impact on platelet adhesion to the endothelium after shock conditions: a protective effect?","volume":"98","author":"Karadjoff","year":"2025","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"R45-20261118","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12959-023-00540-0","article-title":"Tranexamic acid for haemostasis and beyond: does dose matter?","volume":"21","author":"Lam","year":"2023","journal-title":"Thromb J"},{"issue":"12","key":"R46-20261118","doi-asserted-by":"crossref","first-page":"e0145012","DOI":"10.1371\/journal.pone.0145012","article-title":"Label-free kinetic studies of hemostasis-related biomarkers including D-Dimer using autologous serum transfusion","volume":"10","author":"R\u00fchl","year":"2015","journal-title":"PLoS One"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TA.0000000000005092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:00:24Z","timestamp":1795014024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TA.0000000000005092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000005092","relation":{},"ISSN":["2163-0755","2163-0763"],"issn-type":[{"value":"2163-0755","type":"print"},{"value":"2163-0763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"2025-12-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}